Clinical Outcome of a Simplified Technique for Aortic Valve Replacement with Stentless Bioprostheses

被引:0
|
作者
Di Matteo, Gerardo [1 ]
Masala, Nicola [1 ]
Swanevelder, Justiaan [2 ]
Davies, Joan [3 ]
Galinanes, Manuel [1 ]
Sosnowski, Andrzej W. [1 ]
机构
[1] Univ Leicester, Dept Cardiac Surg & Cardiovasc Sci, Coronary Care Unit, Glenfield Hosp,Univ Hosp Leicester NHS Trust, Leicester LE3 9QP, Leics, England
[2] Univ Leicester, Dept Anaesthesia, Coronary Care Unit, Glenfield Hosp,Univ Hosp Leicester NHS Trust, Leicester LE3 9QP, Leics, England
[3] Univ Leicester, Dept Cardiol, Coronary Care Unit, Glenfield Hosp,Univ Hosp Leicester NHS Trust, Leicester LE3 9QP, Leics, England
来源
JOURNAL OF HEART VALVE DISEASE | 2009年 / 18卷 / 01期
关键词
FOLLOW-UP; SUTURE LINE; EXPERIENCE; IMPLANTATION; XENOGRAFTS; PROSTHESIS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aim of the study: Aortic stentless bio-prostheses provide good clinical and hemodynamic results, but may be difficult to implant. Their use is also contraindicated in the presence of a severely calcified aortic root. The study aim was to assess the mid-term results of a simplified implant technique of the Sorin Pericarbon Freedom stentless bioprosthesis (SPF), that allows its use in the presence of severe aortic root calcification. Methods: Between 2001 and 2007, a total of 51 patients underwent aortic valve replacement (AVR) with the SPF, using a new technique which consisted of standard annular fixation and the fixation of each strut with a single 'U' stitch. The perioperative characteristics, early and late mortality and occurrence of valve-related events were evaluated. The overall mean cross-clamp and cardiopulmonary bypass times were 91.5 +/- 30.2 and 125.3 +/- 44.9 min, respectively, and 77.8 +/- 17.7 and 105.6 +/- 22.8 min, respectively, for AVR (these times were comparable to those required in patients receiving stented valve bioprostheses). The mean follow up period was 40.5 months (range: 3-75 months), and was 100% complete. Results: Hospital mortality was 4% and survival 76.5 +/- 14.5% at six years. Late deaths occurred in eight patients; in four cases this was valve-related (1.9%/patient-year). Freedom from valve-related death and reoperation was 91 +/- 9% and 98 +/- 2% respectively, at six years. The mean transprosthetic gradients were 12.0 +/- 3.4, 9.9 +/- 2.6, 8.7 +/- 4.2, 5.2 +/- 3.9, 4.5 +/- 3.0 and 3.2 +/- 2.7 mmHg for the 19, 21, 23, 25, 27 and 29 mm valve sizes, respectively. No valvular or paravalvular regurgitation was recorded. Conclusion: This new implantation technique for the aortic SPF stentless bioprosthesis is simple, effective and versatile, and showed good early results. It may be applicable to other stentless bioprostheses, and also be particularly useful in patients with small aortic annulus and in those with a calcified aortic root.
引用
收藏
页码:111 / 118
页数:8
相关论文
共 50 条
  • [21] Stentless xenografts for aortic valve replacement
    Doty, JR
    Doty, DB
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2003, 17 (02) : 240 - 251
  • [22] Stentless aortic valve replacement: an update
    Kobayashi, Junjiro
    VASCULAR HEALTH AND RISK MANAGEMENT, 2011, 7 : 345 - 351
  • [23] Outcome of Aortic Valve and/or Root Replacement with Stentless Bioprosthesis in Guch Patients
    Michielon, G.
    Brancaccio, G.
    Carlo, D. D.
    Amodeo, A.
    Perri, G.
    Toscano, A.
    Carotti, A.
    Pongiglione, G.
    CARDIOLOGY, 2012, 121 (02) : 120 - 120
  • [24] Impact of implant technique on clinical outcomes following freestyle stentless tissue aortic valve replacement
    Bach, DS
    Cartier, PA
    Dumesnil, JG
    Kon, N
    Doty, DD
    CIRCULATION, 2000, 102 (18) : 372 - 372
  • [25] Impact of implant technique following freestyle stentless aortic valve replacement
    Bach, DS
    Cartier, PC
    Kon, ND
    Johnson, KG
    Deeb, GM
    Doty, DB
    ANNALS OF THORACIC SURGERY, 2002, 74 (04): : 1107 - 1113
  • [26] Clinical outcomes after aortic valve replacement with the Toronto stentless porcine valve
    Goldman, BS
    David, TE
    Wood, JR
    Pepper, JR
    Goldman, SM
    Verrier, ED
    Petracek, MR
    ANNALS OF THORACIC SURGERY, 2001, 71 (05): : S302 - S305
  • [27] Stentless aortic valve replacement in patients with bicuspid aortic valve disease: clinical outcome and aortic diameter changes during follow-up
    Ali, Ayyaz
    Patel, Amit
    Ali, Ziad A.
    Abu-Omar, Yasir
    Freed, Darren
    Sheikh, Ahmad Y.
    Athanasiou, Thanos
    Pepper, John
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2010, 38 (02) : 134 - 140
  • [28] Bioprosthetic Valve Durability After Stentless Aortic Valve Replacement: The Effect of Implantation Technique
    Mohammadi, Siamak
    Kalavrouziotis, Dimitri
    Voisine, Pierre
    Dumont, Eric
    Doyle, Daniel
    Perron, Jean
    Dagenais, Francois
    ANNALS OF THORACIC SURGERY, 2014, 97 (06): : 2011 - 2018
  • [29] Stentless and stented aortic valve replacement in elderly patients:: factors affecting midterm clinical and hemodynamical outcome
    Bove, Thierry
    Van Belleghem, Yves
    Francois, Katrien
    Caes, Frank
    Van Overbeke, Hans
    Van Nooten, Guido
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2006, 30 (05) : 706 - 713
  • [30] Stentless bioprostheses: a versatile and durable solution in extensive aortic valve endocarditisaEuro
    Schneider, Adriaan W.
    Hazekamp, Mark G.
    Versteegh, Michel I. M.
    Bruggemans, Eline F.
    Holman, Eduard R.
    Klautz, Robert J. M.
    Braun, Jerry
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2016, 49 (06) : 1699 - 1704